Share Price and Basic Stock Data
Last Updated: November 15, 2025, 11:11 pm
| PEG Ratio | 0.66 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Fluidomat Ltd operates in the engineering sector, focusing on providing innovative solutions. The company has demonstrated a notable growth trajectory, with sales rising from ₹33 Cr in FY 2022 to ₹45 Cr in FY 2023, and projected to reach ₹55 Cr in FY 2024. This trend continued with quarterly sales figures showing a quarterly increase from ₹12.56 Cr in Jun 2023 to ₹14.65 Cr in Sep 2023, and further to ₹15.65 Cr in Mar 2024. The sales growth reflects a robust demand for its products, bolstered by an operating profit margin (OPM) that stood at 27% for FY 2023, rising to 27% in FY 2024. The company’s strategic initiatives and market positioning have allowed it to capture a growing share of the engineering market, which is crucial for maintaining its competitive edge. Overall, Fluidomat’s revenue trends illustrate a consistent upward trajectory, indicating a strong market presence and effective management.
Profitability and Efficiency Metrics
Fluidomat Ltd has reported impressive profitability metrics, highlighted by a return on equity (ROE) of 31.4% and a return on capital employed (ROCE) of 42.2%. The net profit for FY 2023 was ₹10 Cr, which is projected to rise to ₹22 Cr in FY 2025. The operating profit margin for the latest quarter stood at 24.86%, affirming the company’s efficiency in managing costs relative to sales. The interest coverage ratio recorded an extraordinary 136,101 times, indicating no debt and a strong ability to meet any financial obligations. The cash conversion cycle of 147 days demonstrates effective management of working capital, although it shows a slight increase from previous periods, indicating a need for closer monitoring. The company’s ability to maintain such high profitability metrics while operating without debt sets it apart from many competitors in the sector, which typically have lower ROE and ROCE figures.
Balance Sheet Strength and Financial Ratios
Fluidomat Ltd’s balance sheet reflects considerable strength, with total assets increasing from ₹60 Cr in FY 2023 to ₹93 Cr in FY 2025. The absence of borrowings underscores the company’s conservative financial strategy, which enhances its resilience against market volatility. Reserves have grown significantly, standing at ₹76 Cr, indicating a solid foundation for future investments and dividends. The price-to-book value (P/BV) ratio is recorded at 2.10x, aligning with industry norms, suggesting that the market values the company in line with its underlying asset base. The current ratio of 2.74x demonstrates robust liquidity, well above the typical sector benchmark, ensuring that the company can comfortably meet its short-term obligations. These financial ratios collectively indicate a well-capitalized firm that is positioned to leverage growth opportunities while maintaining financial stability.
Shareholding Pattern and Investor Confidence
As of the latest reports, Fluidomat Ltd has a stable shareholding structure, with promoters holding 53.45% of the equity, reflecting strong control and confidence in the company’s future direction. Public shareholding accounts for 45.96%, indicating a diversified ownership base that can enhance liquidity in the stock. The presence of foreign institutional investors (FIIs) at 0.58% suggests some level of international interest, although it remains low relative to many peers, which may point to untapped potential for attracting foreign capital. The number of shareholders has increased significantly, from 5,214 in Dec 2022 to 10,273 by Jun 2025, indicating growing retail interest and confidence in the company’s performance. This trend is critical for sustaining market momentum and can lead to improved stock performance as investor sentiment strengthens.
Outlook, Risks, and Final Insight
Fluidomat Ltd is well-positioned for continued growth, driven by its robust financial health and operational efficiency. However, risks such as potential market fluctuations and increased competition in the engineering sector could pose challenges. The company’s reliance on domestic markets may limit growth opportunities if economic conditions worsen. Moreover, while the absence of debt is a strength, it may also restrict leverage for strategic acquisitions. In a scenario where market conditions remain favorable, Fluidomat could further enhance its market share and profitability, potentially leading to higher valuations. Conversely, if economic pressures arise, the company might face downward pressure on sales and profitability. Overall, Fluidomat’s strong fundamentals suggest a promising outlook, contingent upon maintaining operational excellence and adapting to market dynamics.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Fluidomat Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| KPT Industries Ltd | 221 Cr. | 650 | 1,121/541 | 17.6 | 218 | 0.46 % | 25.5 % | 22.5 % | 5.00 |
| Miven Machine Tools Ltd | 28.8 Cr. | 96.0 | 112/58.9 | 19.4 | 0.00 % | % | % | 10.0 | |
| Incon Engineers Ltd | 6.19 Cr. | 14.3 | 18.4/9.31 | 1.25 | 0.00 % | 64.2 % | % | 10.0 | |
| Hittco Tools Ltd | 8.62 Cr. | 14.0 | 16.0/10.3 | 5.07 | 0.00 % | 3.21 % | 0.29 % | 10.0 | |
| Harshil Agrotech Ltd | 56.9 Cr. | 0.61 | 13.9/0.48 | 6.84 | 1.27 | 0.00 % | 17.4 % | 16.4 % | 1.00 |
| Industry Average | 3,576.28 Cr | 473.83 | 54.38 | 118.25 | 0.27% | 37.74% | 16.87% | 6.04 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.91 | 13.03 | 9.92 | 14.29 | 12.56 | 14.65 | 12.63 | 15.65 | 15.59 | 19.00 | 16.64 | 20.95 | 12.39 |
| Expenses | 6.99 | 9.15 | 7.83 | 9.84 | 9.19 | 10.44 | 9.53 | 11.45 | 10.39 | 11.32 | 10.64 | 12.55 | 9.31 |
| Operating Profit | 1.92 | 3.88 | 2.09 | 4.45 | 3.37 | 4.21 | 3.10 | 4.20 | 5.20 | 7.68 | 6.00 | 8.40 | 3.08 |
| OPM % | 21.55% | 29.78% | 21.07% | 31.14% | 26.83% | 28.74% | 24.54% | 26.84% | 33.35% | 40.42% | 36.06% | 40.10% | 24.86% |
| Other Income | 0.35 | 0.39 | 0.36 | 0.17 | 0.59 | 0.70 | 0.58 | 1.58 | 0.67 | 0.76 | 1.33 | 0.70 | 0.79 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.20 | 0.20 | 0.20 | 0.14 | 0.19 | 0.19 | 0.18 | 0.20 | 0.21 | 0.23 | 0.23 | 0.27 | 0.29 |
| Profit before tax | 2.07 | 4.07 | 2.25 | 4.48 | 3.77 | 4.72 | 3.50 | 5.58 | 5.66 | 8.21 | 7.10 | 8.83 | 3.58 |
| Tax % | 25.12% | 25.06% | 24.00% | 26.34% | 26.53% | 25.21% | 25.43% | 25.63% | 25.09% | 24.73% | 23.66% | 27.63% | 25.14% |
| Net Profit | 1.55 | 3.05 | 1.71 | 3.30 | 2.77 | 3.52 | 2.61 | 4.15 | 4.24 | 6.17 | 5.42 | 6.39 | 2.68 |
| EPS in Rs | 3.15 | 6.19 | 3.47 | 6.70 | 5.62 | 7.14 | 5.30 | 8.42 | 8.61 | 12.52 | 11.00 | 12.97 | 5.44 |
Last Updated: August 19, 2025, 3:35 pm
Below is a detailed analysis of the quarterly data for Fluidomat Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 12.39 Cr.. The value appears to be declining and may need further review. It has decreased from 20.95 Cr. (Mar 2025) to 12.39 Cr., marking a decrease of 8.56 Cr..
- For Expenses, as of Jun 2025, the value is 9.31 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.55 Cr. (Mar 2025) to 9.31 Cr., marking a decrease of 3.24 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.08 Cr.. The value appears to be declining and may need further review. It has decreased from 8.40 Cr. (Mar 2025) to 3.08 Cr., marking a decrease of 5.32 Cr..
- For OPM %, as of Jun 2025, the value is 24.86%. The value appears to be declining and may need further review. It has decreased from 40.10% (Mar 2025) to 24.86%, marking a decrease of 15.24%.
- For Other Income, as of Jun 2025, the value is 0.79 Cr.. The value appears strong and on an upward trend. It has increased from 0.70 Cr. (Mar 2025) to 0.79 Cr., marking an increase of 0.09 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.27 Cr. (Mar 2025) to 0.29 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is 3.58 Cr.. The value appears to be declining and may need further review. It has decreased from 8.83 Cr. (Mar 2025) to 3.58 Cr., marking a decrease of 5.25 Cr..
- For Tax %, as of Jun 2025, the value is 25.14%. The value appears to be improving (decreasing) as expected. It has decreased from 27.63% (Mar 2025) to 25.14%, marking a decrease of 2.49%.
- For Net Profit, as of Jun 2025, the value is 2.68 Cr.. The value appears to be declining and may need further review. It has decreased from 6.39 Cr. (Mar 2025) to 2.68 Cr., marking a decrease of 3.71 Cr..
- For EPS in Rs, as of Jun 2025, the value is 5.44. The value appears to be declining and may need further review. It has decreased from 12.97 (Mar 2025) to 5.44, marking a decrease of 7.53.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:21 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28 | 28 | 27 | 26 | 24 | 27 | 25 | 28 | 33 | 45 | 55 | 71 | 69 |
| Expenses | 20 | 20 | 21 | 22 | 21 | 24 | 22 | 23 | 26 | 33 | 40 | 43 | 44 |
| Operating Profit | 8 | 8 | 6 | 4 | 3 | 3 | 3 | 5 | 6 | 12 | 15 | 27 | 25 |
| OPM % | 30% | 28% | 21% | 15% | 12% | 11% | 13% | 17% | 19% | 27% | 27% | 39% | 36% |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 3 | 3 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 8 | 8 | 6 | 4 | 3 | 3 | 4 | 5 | 7 | 13 | 18 | 30 | 28 |
| Tax % | 33% | 33% | 33% | 34% | 26% | 28% | 25% | 26% | 26% | 25% | 26% | 25% | |
| Net Profit | 6 | 5 | 4 | 3 | 2 | 2 | 3 | 4 | 5 | 10 | 13 | 22 | 21 |
| EPS in Rs | 11.57 | 10.82 | 8.06 | 5.58 | 4.73 | 4.85 | 6.49 | 8.08 | 11.14 | 19.53 | 26.49 | 45.10 | 41.93 |
| Dividend Payout % | 24% | 25% | 31% | 31% | 37% | 41% | 35% | 40% | 31% | 23% | 17% | 17% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -16.67% | -20.00% | -25.00% | -33.33% | 0.00% | 50.00% | 33.33% | 25.00% | 100.00% | 30.00% | 69.23% |
| Change in YoY Net Profit Growth (%) | 0.00% | -3.33% | -5.00% | -8.33% | 33.33% | 50.00% | -16.67% | -8.33% | 75.00% | -70.00% | 39.23% |
Fluidomat Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 23% |
| 3 Years: | 29% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 47% |
| 3 Years: | 62% |
| TTM: | 42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 59% |
| 3 Years: | 80% |
| 1 Year: | 35% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 22% |
| 3 Years: | 26% |
| Last Year: | 31% |
Last Updated: September 5, 2025, 3:30 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 88 | 103 | 164 | 122 | 160 | 139 | 118 | 117 | 120 | 110 | 90 | 116 |
| Inventory Days | 155 | 212 | 223 | 165 | 181 | 142 | 214 | 189 | 141 | 141 | 113 | 84 |
| Days Payable | 72 | 89 | 75 | 58 | 92 | 79 | 118 | 123 | 137 | 91 | 70 | 53 |
| Cash Conversion Cycle | 170 | 225 | 312 | 228 | 249 | 202 | 214 | 183 | 124 | 159 | 132 | 147 |
| Working Capital Days | 64 | 94 | 164 | 133 | 185 | 169 | 171 | 159 | 146 | 90 | 150 | 155 |
| ROCE % | 45% | 35% | 23% | 15% | 10% | 11% | 13% | 15% | 18% | 29% | 32% | 42% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 19.48 | 11.65 | 8.93 | 6.05 |
| Diluted EPS (Rs.) | 19.48 | 11.65 | 8.93 | 6.05 |
| Cash EPS (Rs.) | 21.01 | 12.47 | 9.39 | 7.82 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 99.84 | 83.86 | 75.45 | 66.52 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 99.84 | 83.86 | 75.45 | 66.52 |
| Revenue From Operations / Share (Rs.) | 93.68 | 69.15 | 57.38 | 51.74 |
| PBDIT / Share (Rs.) | 27.62 | 15.73 | 12.30 | 10.01 |
| PBIT / Share (Rs.) | 26.12 | 14.38 | 11.00 | 8.66 |
| PBT / Share (Rs.) | 26.12 | 15.05 | 10.95 | 8.65 |
| Net Profit / Share (Rs.) | 19.51 | 11.12 | 8.09 | 6.47 |
| NP After MI And SOA / Share (Rs.) | 19.51 | 11.12 | 8.09 | 6.47 |
| PBDIT Margin (%) | 29.48 | 22.75 | 21.43 | 19.33 |
| PBIT Margin (%) | 27.88 | 20.79 | 19.16 | 16.74 |
| PBT Margin (%) | 27.88 | 21.76 | 19.08 | 16.72 |
| Net Profit Margin (%) | 20.82 | 16.07 | 14.09 | 12.51 |
| NP After MI And SOA Margin (%) | 20.82 | 16.07 | 14.09 | 12.51 |
| Return on Networth / Equity (%) | 19.53 | 13.25 | 10.72 | 9.73 |
| Return on Capital Employeed (%) | 25.54 | 16.69 | 14.21 | 12.66 |
| Return On Assets (%) | 16.03 | 10.69 | 8.87 | 7.77 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.02 |
| Asset Turnover Ratio (%) | 0.83 | 0.70 | 0.65 | 0.00 |
| Current Ratio (X) | 2.74 | 2.86 | 3.06 | 2.79 |
| Quick Ratio (X) | 2.07 | 2.32 | 2.25 | 2.05 |
| Inventory Turnover Ratio (X) | 3.10 | 2.36 | 1.90 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 17.94 | 29.23 | 0.00 | 30.88 |
| Dividend Payout Ratio (CP) (%) | 16.66 | 26.05 | 0.00 | 25.59 |
| Earning Retention Ratio (%) | 82.06 | 70.77 | 0.00 | 69.12 |
| Cash Earning Retention Ratio (%) | 83.34 | 73.95 | 0.00 | 74.41 |
| Interest Coverage Ratio (X) | 136101.00 | 2500.90 | 268.10 | 704.26 |
| Interest Coverage Ratio (Post Tax) (X) | 96208.00 | 1660.16 | 177.38 | 456.79 |
| Enterprise Value (Cr.) | 101.07 | 84.85 | 41.93 | 31.44 |
| EV / Net Operating Revenue (X) | 2.19 | 2.49 | 1.48 | 1.23 |
| EV / EBITDA (X) | 7.43 | 10.94 | 6.92 | 6.38 |
| MarketCap / Net Operating Revenue (X) | 2.24 | 2.55 | 1.52 | 1.23 |
| Retention Ratios (%) | 82.05 | 70.76 | 0.00 | 69.11 |
| Price / BV (X) | 2.10 | 2.10 | 1.15 | 0.95 |
| Price / Net Operating Revenue (X) | 2.24 | 2.55 | 1.52 | 1.23 |
| EarningsYield | 0.09 | 0.06 | 0.09 | 0.10 |
After reviewing the key financial ratios for Fluidomat Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 23, the value is 19.48. This value is within the healthy range. It has increased from 11.65 (Mar 22) to 19.48, marking an increase of 7.83.
- For Diluted EPS (Rs.), as of Mar 23, the value is 19.48. This value is within the healthy range. It has increased from 11.65 (Mar 22) to 19.48, marking an increase of 7.83.
- For Cash EPS (Rs.), as of Mar 23, the value is 21.01. This value is within the healthy range. It has increased from 12.47 (Mar 22) to 21.01, marking an increase of 8.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 99.84. It has increased from 83.86 (Mar 22) to 99.84, marking an increase of 15.98.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 99.84. It has increased from 83.86 (Mar 22) to 99.84, marking an increase of 15.98.
- For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 93.68. It has increased from 69.15 (Mar 22) to 93.68, marking an increase of 24.53.
- For PBDIT / Share (Rs.), as of Mar 23, the value is 27.62. This value is within the healthy range. It has increased from 15.73 (Mar 22) to 27.62, marking an increase of 11.89.
- For PBIT / Share (Rs.), as of Mar 23, the value is 26.12. This value is within the healthy range. It has increased from 14.38 (Mar 22) to 26.12, marking an increase of 11.74.
- For PBT / Share (Rs.), as of Mar 23, the value is 26.12. This value is within the healthy range. It has increased from 15.05 (Mar 22) to 26.12, marking an increase of 11.07.
- For Net Profit / Share (Rs.), as of Mar 23, the value is 19.51. This value is within the healthy range. It has increased from 11.12 (Mar 22) to 19.51, marking an increase of 8.39.
- For NP After MI And SOA / Share (Rs.), as of Mar 23, the value is 19.51. This value is within the healthy range. It has increased from 11.12 (Mar 22) to 19.51, marking an increase of 8.39.
- For PBDIT Margin (%), as of Mar 23, the value is 29.48. This value is within the healthy range. It has increased from 22.75 (Mar 22) to 29.48, marking an increase of 6.73.
- For PBIT Margin (%), as of Mar 23, the value is 27.88. This value exceeds the healthy maximum of 20. It has increased from 20.79 (Mar 22) to 27.88, marking an increase of 7.09.
- For PBT Margin (%), as of Mar 23, the value is 27.88. This value is within the healthy range. It has increased from 21.76 (Mar 22) to 27.88, marking an increase of 6.12.
- For Net Profit Margin (%), as of Mar 23, the value is 20.82. This value exceeds the healthy maximum of 10. It has increased from 16.07 (Mar 22) to 20.82, marking an increase of 4.75.
- For NP After MI And SOA Margin (%), as of Mar 23, the value is 20.82. This value exceeds the healthy maximum of 20. It has increased from 16.07 (Mar 22) to 20.82, marking an increase of 4.75.
- For Return on Networth / Equity (%), as of Mar 23, the value is 19.53. This value is within the healthy range. It has increased from 13.25 (Mar 22) to 19.53, marking an increase of 6.28.
- For Return on Capital Employeed (%), as of Mar 23, the value is 25.54. This value is within the healthy range. It has increased from 16.69 (Mar 22) to 25.54, marking an increase of 8.85.
- For Return On Assets (%), as of Mar 23, the value is 16.03. This value is within the healthy range. It has increased from 10.69 (Mar 22) to 16.03, marking an increase of 5.34.
- For Total Debt / Equity (X), as of Mar 23, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 23, the value is 0.83. It has increased from 0.70 (Mar 22) to 0.83, marking an increase of 0.13.
- For Current Ratio (X), as of Mar 23, the value is 2.74. This value is within the healthy range. It has decreased from 2.86 (Mar 22) to 2.74, marking a decrease of 0.12.
- For Quick Ratio (X), as of Mar 23, the value is 2.07. This value exceeds the healthy maximum of 2. It has decreased from 2.32 (Mar 22) to 2.07, marking a decrease of 0.25.
- For Inventory Turnover Ratio (X), as of Mar 23, the value is 3.10. This value is below the healthy minimum of 4. It has increased from 2.36 (Mar 22) to 3.10, marking an increase of 0.74.
- For Dividend Payout Ratio (NP) (%), as of Mar 23, the value is 17.94. This value is below the healthy minimum of 20. It has decreased from 29.23 (Mar 22) to 17.94, marking a decrease of 11.29.
- For Dividend Payout Ratio (CP) (%), as of Mar 23, the value is 16.66. This value is below the healthy minimum of 20. It has decreased from 26.05 (Mar 22) to 16.66, marking a decrease of 9.39.
- For Earning Retention Ratio (%), as of Mar 23, the value is 82.06. This value exceeds the healthy maximum of 70. It has increased from 70.77 (Mar 22) to 82.06, marking an increase of 11.29.
- For Cash Earning Retention Ratio (%), as of Mar 23, the value is 83.34. This value exceeds the healthy maximum of 70. It has increased from 73.95 (Mar 22) to 83.34, marking an increase of 9.39.
- For Interest Coverage Ratio (X), as of Mar 23, the value is 136,101.00. This value is within the healthy range. It has increased from 2,500.90 (Mar 22) to 136,101.00, marking an increase of 133,600.10.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 96,208.00. This value is within the healthy range. It has increased from 1,660.16 (Mar 22) to 96,208.00, marking an increase of 94,547.84.
- For Enterprise Value (Cr.), as of Mar 23, the value is 101.07. It has increased from 84.85 (Mar 22) to 101.07, marking an increase of 16.22.
- For EV / Net Operating Revenue (X), as of Mar 23, the value is 2.19. This value is within the healthy range. It has decreased from 2.49 (Mar 22) to 2.19, marking a decrease of 0.30.
- For EV / EBITDA (X), as of Mar 23, the value is 7.43. This value is within the healthy range. It has decreased from 10.94 (Mar 22) to 7.43, marking a decrease of 3.51.
- For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 2.24. This value is within the healthy range. It has decreased from 2.55 (Mar 22) to 2.24, marking a decrease of 0.31.
- For Retention Ratios (%), as of Mar 23, the value is 82.05. This value exceeds the healthy maximum of 70. It has increased from 70.76 (Mar 22) to 82.05, marking an increase of 11.29.
- For Price / BV (X), as of Mar 23, the value is 2.10. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 2.10.
- For Price / Net Operating Revenue (X), as of Mar 23, the value is 2.24. This value is within the healthy range. It has decreased from 2.55 (Mar 22) to 2.24, marking a decrease of 0.31.
- For EarningsYield, as of Mar 23, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 22) to 0.09, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fluidomat Ltd:
- Net Profit Margin: 20.82%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 25.54% (Industry Average ROCE: 37.74%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 19.53% (Industry Average ROE: 16.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 96208
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 20.1 (Industry average Stock P/E: 54.38)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 20.82%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Engineering - General | 117, 1st Floor, Navneet Darshan, Indore Madhya Pradesh 452018 | info@fluidomat.com http://www.fluidomat.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashok Jain | Chairman & Managing Director |
| Mrs. Radhica Sharma | Deputy Managing Director |
| Mr. Kunal Jain | Executive Director |
| Mr. Ashok Kumar Patni | Independent Director |
| Mr. Sharad Panot | Independent Director |
| Mr. Samyak Modi | Independent Director |